Xponance Inc. Has $2.32 Million Stock Position in Celsius Holdings, Inc. (NASDAQ:CELH)

Xponance Inc. increased its holdings in shares of Celsius Holdings, Inc. (NASDAQ:CELH) by 7.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,607 shares of the company’s stock after buying an additional 2,928 shares during the quarter. Xponance Inc.’s holdings in Celsius were worth $2,318,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CELH. Vanguard Group Inc. grew its position in shares of Celsius by 183.6% in the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock valued at $749,458,000 after purchasing an additional 8,899,873 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in Celsius by 231.2% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after buying an additional 2,754,722 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Celsius by 212.2% in the fourth quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after buying an additional 2,306,598 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of Celsius by 424.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock worth $152,287,000 after acquiring an additional 2,261,046 shares in the last quarter. Finally, Eagle Asset Management Inc. raised its holdings in shares of Celsius by 188.8% during the fourth quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock worth $161,312,000 after acquiring an additional 1,934,400 shares during the period. 60.95% of the stock is currently owned by institutional investors.

Celsius Price Performance

CELH stock opened at $31.32 on Friday. Celsius Holdings, Inc. has a one year low of $30.86 and a one year high of $99.62. The stock has a market cap of $7.30 billion, a price-to-earnings ratio of 34.42, a price-to-earnings-growth ratio of 2.45 and a beta of 1.85. The company has a fifty day moving average price of $39.17 and a two-hundred day moving average price of $62.58.

Celsius (NASDAQ:CELH) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The business had revenue of $402.00 million for the quarter, compared to analyst estimates of $391.07 million. During the same quarter in the prior year, the business earned $0.17 EPS. Celsius’s quarterly revenue was up 23.4% on a year-over-year basis. Research analysts anticipate that Celsius Holdings, Inc. will post 0.82 EPS for the current fiscal year.

Insider Buying and Selling

In other Celsius news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the transaction, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Truist Financial reduced their target price on shares of Celsius from $45.00 to $30.00 and set a “hold” rating for the company in a research note on Friday, September 6th. TD Cowen decreased their price objective on Celsius from $68.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Bank of America cut their target price on Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research note on Thursday, September 5th. Stifel Nicolaus decreased their price target on shares of Celsius from $61.00 to $51.00 and set a “buy” rating for the company in a research note on Thursday, September 5th. Finally, Piper Sandler cut their price objective on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating on the stock in a research report on Tuesday. One analyst has rated the stock with a sell rating, two have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Celsius currently has an average rating of “Moderate Buy” and an average price target of $57.43.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.